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http://dx.doi.org/10.1016/j.ajic.2014.11.016Background: Endemic health care-associated safety problems, including health care-associated infection,
account for substantial morbidity and mortality. We outline a regional No Preventable Harms campaign
to reduce these safety problems and describe the initial results from the ﬁrst initiative focusing on
catheter-associated urinary tract infection (CAUTI) prevention.
Methods: We formed a think tank composed of multidisciplinary experts from within a 7-hospital
Midwestern Veterans Affairs network to identify hospital-acquired conditions that had strong evi-
dence on how to prevent the harm and outcome data that could be easily collected to evaluate
improvement efforts. The ﬁrst initiative of this campaign focused on CAUTI prevention. Quantitative data
on CAUTI rates and qualitative data from site visit interviews were used to evaluate the initiative.
Results: Quantitative data showed a signiﬁcant reduction in CAUTI rates per 1,000 catheter days for
nonintensive care units across the region (2.4 preinitiative and 0.8 postinitiative; P ¼ .001), but no
improvement in the intensive care unit rate (1.4 preinitiative and 2.1 postinitiative; P ¼ .16). Themes that
emerged from our qualitative data highlight the need for considering local context and the importance of
communication when developing and implementing regional initiatives.
Conclusions: A regional collaborative can be a valuable strategy for addressing important endemic pa-
tient safety problems.
Published by Elsevier Inc. on behalf of the Association for Professionals in Infection Control and
Epidemiology, Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/)., Veterans Affairs Ann Arbor
30W, Ann Arbor, MI 48109-
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Association for Professionals in Infe
y-nc-nd/3.0/).The Institute of Medicine’s seminal report on patient safety, To
Err Is Human,1 led to widespread efforts to improve the safety of
patients; yet, much work remains. Patient safety hazards range
from rare, but catastrophic “never events”2 such as operating on
the wrong patient or amputating the wrong limb to less news-
worthy problems that occur every day in hospitals around the
world such as developing delirium or a pressure ulcer. These
endemic health care-associated safety problems, which include
health care-associated infection, account for far greater morbidity
and mortality than “never events.” Although efforts addressing
safety have increased in recent years, the absence of a frameworkction Control and Epidemiology, Inc. This is an open access article under the CC BY-
Table 1
No Preventable Harms campaign think tank’s scope and goals
Questions discussed during think tank formation Decisions
What are the harms we’d like to prevent? Common, important harms, ideally where outcome data is already being collected, to minimize
burden to hospitals
Where do we get the evidence and practices? Published peer-reviewed literature and ideally a successful pilot study at 1 of 7 regional hospitals
Ownership to look at evidence and practices? Membership of the think tank and/or ad hoc experts from regional hospitals
Deﬁnition of scope (inpatient, outpatient, long-term care)? Initial focus will be inpatient care, speciﬁcally preventing hospital-acquired conditions
Determination of overarching strategy? Go slow and ensure initial success
How will we know it is working? Set up evaluation plan with each initiative, minimizing data collection burden. Compare results
with other Veterans Affairs hospitals that are not participating in the initiative
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to demonstrate progress in patient safety.3 Recognizing this, a
translational research framework for reducing preventable
harmdranging from discovery to implementation and
evaluationdhas been proposed.4 Coordinated and structured ap-
proaches organized at the health system,5-7 regional,8-10 and na-
tional11 levels have demonstrated signiﬁcant reductions in
preventable deaths, health care-associated infection, and costs.
These successes, marked by leadership support, clearly stated
goals, organization-wide cooperative efforts, and transparency of
results, offer promising insights into how the national goals of
reducing preventable patient harm can be achieved.
Serving almost 9 million veterans each year, the Veterans
Healthcare Administration (VHA) is the largest integrated health
care system in the United States,12 and 1 of the largest in the world.
A broad spectrum of services is available to veterans, including
primary, acute medical, surgical, psychiatric, rehabilitative, and
long-term care. The VHA, which manages 150 hospitals, more than
800 community-based outpatient clinics, and 135 nursing home
care units, is organized into 21 regional networks called Veterans
Integrated Service Networks (VISNs).13 Each VISN coordinates the
activities of the medical facilities in its region to better meet vet-
erans’ health care needs.
One such regional network, VISN 11, which includes 7 acute care
hospitals and 29 community-based outpatient clinics located in
central Illinois, Indiana, Michigan, and northwest Ohio, engaged in
a campaign to aggressively enhance veteran safety by addressing
harms in the acute care setting. This initiative is called the No
Preventable Harms campaign and is led by regional leadership. Our
objective is to describe the overall campaign and provide pre-
liminary results of the ﬁrst initiative. Our overarching purpose is to
provide guidance to infection control professionals who work as
part of larger health care systems and are involved in implementing
best practices to prevent infection. Given the movement in the
United States of health care increasingly being delivered as part of
accountable care organizations,14 such guidance may be useful to
enhance the safety of hospitalized patients.METHODS
Overview of the No Preventable Harms campaign
During March 2011 the regional leadership formed a think tank,
which was tasked with developing initiatives to help keep veteran
patients safe. A multidisciplinary team of patient safety experts was
recruited from the 7 regional hospitals. The explicit goal was to
create the safest health care system in the world, 1 region at a time
beginning with VISN 11. At the ﬁrst meeting, the regional director
led the think tank in a discussion to identify the scope and objec-
tives of the No Preventable Harms campaign (Table 1).
The think tank decided to initially focus on the acute care setting
because data for evaluation was already being collected andreported to the Department of Veterans Affairs (VA) Inpatient
Evaluation Center (IPEC),15 a national quality improvement pro-
gram that electronically collects data from VA computer databases
and through facility reports to monitor evidence-based practices.
To accomplish this, the think tank adopted the following principles:
1. The harm should be a hospital-acquired condition that health
careworkers within the regionwould likely consider important
to prevent;
2. There should be data that are currently being collected (eg,
IPEC data) to evaluate the incidence of the harm or include data
collection as part of the intervention (a so-called measure-
vention);16
3. The evidence to prevent the harm must be strong and come
from the peer-reviewed literature ideally coupled with pilot
implementation at a VA (or non-VA) hospital with proven
success;
4. Explicit guidance should be available to the hospitals on how to
implement changes and how to ramp-up efforts if they are not
achieving the goal reductions in the complication; and
5. The campaign initiatives would be evaluated using both
quantitative and qualitative assessment, and lead to changes in
the initiative and future initiatives as necessary.
Based on these criteria, the think tank identiﬁed patient harms
with strong evidence for prevention strategies, such as health care-
associated infection,17 given the clinical and economic conse-
quences of each episode. Next, initiatives were identiﬁed to prevent
these harms that had been successful at either a single medical
center or a group of hospitals. Finally, programs were developed to
promote spread of these initiatives throughout the entire region,
focusing on a single complication at a time.Catheter-associated urinary tract infection (CAUTI) prevention
The ﬁrst harm chosen to be addressed throughout the region as
part of the No Preventable Harms campaign was CAUTI. We chose
CAUTI for several reasons. Approximately 25% of hospitalized pa-
tients have an indwelling urinary catheter at any given time,18 and
CAUTI accounts for approximately one-third of all device-related
infections.17 In addition, use of urinary catheters can increase pa-
tient risk for noninfectious complications, such as urethral stric-
ture.19 Given the ubiquity of urinary devices,20 potential
consequences for patients,19,21 and growing costs to hospitals,22,23
safe urinary catheter use should be a priority. Yet CAUTI has
proven difﬁcult to reduce. Studies have shown that urinary catheter
use is inappropriate in at least one-third of the days that patients
are catheterized.24,25 Physicians commonly forget about, or were
never aware of the presence of the catheter, contributing to pro-
longed catheterization.26 Evidence suggests that avoiding unnec-
essary initial placement, as well as the use of urinary catheter
Fig 1. No Preventable Harms campaign 2-tiered approach to catheter-associated urinary tract (CAUTI) prevention. BDOC, bed-days of care; ICU, intensive care unit; VISN, Veterans
Integrated Service Network.
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unneeded catheters can help reduce CAUTI.27,28
The region-wide CAUTI initiative was heavily based on a suc-
cessful intervention that involved a nurse-initiated urinary catheter
removal protocol to promote timely catheter removal and was
initially developed and pilot-tested at the VA Ann Arbor Healthcare
System.29 An electronic medical record nursing template was
developed to assist with daily assessments for the presence of and
appropriateness of urinary catheters based on the Centers for Dis-
easeControl andPreventionguidelines.30The templatealsoprompts
nurses to contact physicians for a removal orderwhen the catheter is
no longer indicated. Standardized closed-system catheter kits were
purchased to help prevent the introduction of bacteria into the
system. At the VA Ann Arbor Healthcare System there was a sizable
decrease in the CAUTI rate after the introduction of the CAUTI Pre-
ventionProgram, from13.1 infectionsper 10,000patientdaysbefore
the intervention to8.0 per 10,000patient days after the intervention
(39% decrease; P ¼ .04). The proportion of inappropriate
cathetersdbased on point prevalence studiesdalso decreased
substantially after the intervention, from 13.3% to 2.3% (P ¼ .06).29
We took a stepwise approach to addressing CAUTI in the other 6
hospitals of VISN 11. The ﬁrst step, reviewing CAUTI rates across the
region, led to the conclusion that the region-wide CAUTI rate was
well above the collaborative target rate of 2 CAUTI per 1,000
catheter days (admittedly with some variability among hospitals).
This benchmark was based on the median national rate reported by
the National Healthcare Safety Network (NHSN), stratiﬁed by type
of unit (intensive care unit [ICU] or ward).31 Step 2 involved iden-
tifying which urinary products each hospital was using. This
required a survey of each hospital and, in some cases, a conversa-
tion with the infection preventionist or other personnel at each
hospital to identify exactly what products were being used. For
CAUTI prevention, such queries focused on the exact type of Foley
catheter and whether an antimicrobial urinary catheter was being
used, the type of condom catheter used in men, and whether
portable bladder ultrasound scanners were available at the facility.There was also great variability in the processes of care, including
the brands and types of urinary catheters and trays carried by each
facility. For example, in many facilities the catheters were packaged
separate from the insertion tray, which included the drainage bag
and tubing, and were thereby not considered closed drainage sys-
tems. Additionally, some facilities were using antimicrobial cathe-
ters for all insertions despite these catheters often being more
costly and recently were found to not signiﬁcantly reduce CAUTI
when compared with noncoated catheters.32 Step 3 entailed the
regional network ofﬁce providing guidance to each hospital about
the standard practices recommended to prevent CAUTI as well as
additional interventions that should be used if rates were higher
than the agreed upon benchmark, as described inmore detail in the
next section.
Two-tiered approach to CAUTI prevention
The No Preventable Harms CAUTI initiative utilized a 2-tiered
approach for CAUTI prevention (Fig 1). Tier 1 practices are to be
used by all facilities and include daily monitoring for continued
catheter use and use of a standardized catheter kit. The regional
network ofﬁceworked through the contracting procedures to allow
each facility to purchase the recommended standardized closed-
system Foley catheter insertion kits. These kits include directions
for use, a list of the Centers for Disease Control and Prevention
indications for urinary catheter use, an insertion checklist, main-
tenance checklist, and patient education. The supply processing
department at each facility was advised to remove all kits that were
no longer recommended for use as well as individual urinary
catheters from their stock, such as antimicrobial urinary catheters
that were no longer recommended based on the evidence.32 Each
facility was also provided with the electronic nursing template for
monitoring urinary catheter presence and indications for use that
had been pilot-tested at the VA Ann Arbor Healthcare System.
When a catheter is present but deemed not appropriate, nurses are
prompted to contact a physician to discuss removal of the catheter.
Fig 2. Catheter-associated urinary tract infection (CAUTI) rate per 1,000 catheter days
in (A) nonintensive care units (ICU) and (B) ICU units. Time period reported by quarter
year, October 2010-March 2014.
Fig 3. Catheter-associated urinary tract infection (CAUTI) rate per 1,000 catheter days
by month after implementation of a CAUTI initiative. ICU, intensive care unit.
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month. Evaluation was performed using both the NHSN rate of
CAUTI per 1,000 catheter days, as well as a population-based
measure of CAUTI per 10,000 bed days of care.33 If a facility’s
average CAUTI rate for a 6-month period exceeded both of the
assigned thresholds, the facility was encouraged to proceed to the
more time-intensive Tier 2 activities, which included documenting
insertion competency and performing a focused review or root
cause analysis of all CAUTI events (Fig 1).
QUALITATIVE OUTCOMES
Qualitative research is well suited for answering how facilities
implement infection prevention initiatives, factors that may hinder
the process, and how knowledge gained from implementation of 1
initiative can subsequently inform those that follow.34
As part of the evaluation of the program, several team members
(SS, SK, KF, MH, and EG) conducted facility site visits to better un-
derstand how the No Preventable Harms campaign was imple-
mented. A total of 46 interviews across 6 facilities were conducted
focusing on where each site was in the process, barriers they
encountered, and decisions they made in response to those bar-
riers. Our goal of the interviews was 2-fold. First, we wanted to
provide immediate feedback to regional leadership about how the
process was going and what, if any, additional support and re-
sources were needed to help with implementation. Second, we
intended to use our ﬁndings to inform future initiatives.
Given the timeframe for the interviews and need for immediate
feedback to regional leadership, we chose a rapid analysis approach
to analyze our data,35 which entails developing domains, coding
the transcripts with these domains, and then writing summaries ofthe data. Two teammembers (MH and EG) read the transcripts and
summarized the ﬁndings focusing on the factors that impeded
implementation and, given each site’s experience, the feedback
they would provide regional leadership to improve the imple-
mentation process. The summary ﬁndings were then discussed by
team members and veriﬁed. The evaluation of the No Preventable
Harms CAUTI initiative was approved by the VA Ann Arbor insti-
tutional review board.
RESULTS
Using IPEC data, we compared regional CAUTI rates per 1,000
catheter days for the 27 months before (October 2010-December
2012) and 15 months after the initiative (January 2013-March
2014). The average preintervention CAUTI rate per 1,000 catheter
days was 2.4 in non-ICUs and 1.4 in ICUs. That rate decreased to 0.8
CAUTI per 1,000 catheter days (P ¼ .001) in the non-ICUs, but
increased to 2.1 CAUTI per 1,000 catheter days in the ICUs (P ¼ .16)
after the start of the CAUTI initiative (Fig 2 A & B). As demonstrated
in Figure 3, the CAUTI rate per 1,000 catheter days was elevated
during the initial 6 months of the program, but then decreased by
55% in non-ICU units to 0.56 (P ¼ .10) and 76% in the ICU to 0.93
(P < .001) in the next 9 months of the program.
Qualitative evaluation
Some of our major opportunities for improvement (Table 2)
consisted of the role local context and communication had in the
implementation process. For example, the diversity across sites
with respect to patients and services, with some providing less
acute and more long-term care, suggested a need for more ﬂexi-
bility and room for individualization given the local context. Some
sites also expressed a desire for increased communication from the
regional network and for the opportunity to provide more input as
the initiatives are developed and disseminated. Feedback from the
site visit team to regional leadership on initiative development and
implementation highlighted what support and resources could
assist with implementation of future initiatives.
DISCUSSION
We describe a regional patient safety collaborative of 7 hospitals
that are part of the national VHA in which we ﬁrst addressed the
issue of CAUTI. The VHA’s organization into 21 regional networks
makes it an especially successful model to enhance patient safety
and decrease preventable harms. Rather than responding as indi-
vidual hospitals, the collaborative effort of a VISN-wide initiative
Table 2
Feedback to regional network from site visits
Opportunity for improvement Example quote(s)
Consider local policies and procedures “I think it’s a good idea to take into consideration local policies and procedures
about changes in documentation.”
Allow the initiative to be individualized according to site/unit “Make room for the ability of that team on the ground to individualize or
personalize their model because there are some signiﬁcant differences.”
“I think there’s deﬁnitely a need for ﬂexibility. We have to consider the
uniqueness of the patient populations in each facility.”
One initiative at a time/provide time between initiatives “I think if they didn’t do so many at one time, that might help.”
“The ﬁrst thing, give us a break, let us breathe in between.give us time to
adjust and settle into the new changes.”
Make sure all stakeholders are involved in initial conversations and have input “.if we are going to kind of agree to things as a VISN, it might be better to
everyone get together and kind of talk face to face.”
“A really good [clinical applications coordinator].they’ve got their thoughts
together and they’re looking at [it] system-level.”
Be clear about who should be involved at the local level (eg, champions and a
project manager). Involve all affected staff
“Rolling out a new program you need awork group of all your process owners or
it’s going to fail.”
“You need frontline staff, they’re the ones out there doing the work.”
“Yeah that’s what we need [a project manager]. We don’t have that.”
“At each institution there has to be a physician and a nursing champion.”
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gaining and purchasing power, onsite coaching, and an ability to
share experiences between various sites. Indeed, the VHA’s infra-
structure lends itself to national spread once the best practice and
implementation strategy has been identiﬁed through this regional
work. We are currently partnering with the VA National Center for
Patient Safety on a national CAUTI collaborative within the VHA.
Such an evidence-based model to ensure patient safety can help
inform the patient safety work in other countries that have inte-
grated health systems, such as England, Italy, Thailand, Japan, and
others. Through some of our work in such countries36-38 we
recognize the important roles national and regional culture plays in
implementation as recently described by Borg;39 thus, any collab-
orative in these venues should ideally also be based on local and
regionalwork beforewidespread dissemination. Our initial focus on
CAUTI parallels the decision made by the Centers for Medicare and
Medicaid Services to choose CAUTI as the ﬁrst hospital-acquired
condition chosen for nonpayment during 2008.40 Thus far, the No
Preventable Harms campaign appears to have decreased CAUTI
rates in non-ICU settings, a phenomenon also being observed
outside of VHA. Speciﬁcally, a federally funded national collabora-
tive of nearly 1,000 non-VHA hospitals41 had similar ﬁndings to our
VHA project: Preliminary results indicate non-ICUs have decreased
their CAUTI rates by 25%, whereas the rate in ICUs has increased by
5%.42 The reason that ICUs have lagged in CAUTI prevention remains
unclear but could, in part, be related to the culture in many ICUs in
which Foley catheters are considered standard care.
A key strength of our study is the coupling of quantitative results
with site visits that yielded important qualitative ﬁndings that will
be used to inform future initiatives within the No Preventable
Harms campaign as well as spreading CAUTI prevention
throughout VHA. We found that sites were willing to provide
advice for how to better implement regional initiatives, especially
improved communication between the regional network ofﬁce and
individual facilities beginning at the development stages. Specif-
ically, almost all interview participants mentioned communication
as a factor that needed improving. Communication related to such
things as explanations for why the sites were being asked to
implement this initiative, why a new documentation template was
needed, why a speciﬁc catheter product had been chosen, and who
was going to be the onsite coordinator and initiative leader.
In addition to collecting data, the site visit team was able to
provide advice to the facilities regarding any implementation issues
they were encountering. This included technical guidancedproviding a bladder scanner protocol, answering questions related
to use of condom catheters, and discussing application of the NHSN
surveillance deﬁnitiondand socioadaptive advice such as
providing recommendations for additional members of the local
CAUTI prevention team and strategies to promote physician and
nurse engagement.
Because CAUTI prevention includes both technical and socio-
adaptive components, qualitative evaluationdsite visits in
particulardis especially informative and often necessary to fully
understand hospital-speciﬁc challenges and thus make recom-
mendations for improvement. In terms of spreading the CAUTI
initiative throughout the VHA or other large health care networks,
site visits are not practical. We recommend that individual facilities
conduct self-assessments to help identify potential challenges and
strategies for improvement. A recently developed CAUTI Guide to
Patient Safety43 might be a helpful tool for this purpose. The CAUTI
Guide to Patient Safety,43 which is based on lessons learned from
other hospitals’ CAUTI improvement efforts, consists of a brief
assessment process followed by feedback, including possible solu-
tions to speciﬁc issues.CONCLUSIONS
We found that a regional collaborative that includes a multidis-
ciplinary advisory group can address important endemic patient
safety problems such as CAUTI. In the future, we plan to tackle other
hospital-acquired conditions such as central line-associated
bloodstream infection, sepsis, medication reconciliation during
hospital discharge, antimicrobial overuse, and CAUTI in long-term-
care settings. Such a collaborative will leverage the creativity of
individual facilities and the coordinating power of a large regional
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